Tarsus Pharmaceuticals, Inc. · NASDAQ:TARS

Deep Track Capital, LP reported a 8.46% stake in Tarsus Pharmaceuticals, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Deep Track Capital, LP reported a 8.46% stake in Tarsus Pharmaceuticals, Inc., 3,600,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
8.46%
Shares
3,600,000
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP8.46%3,600,000
Deep Track Biotechnology Master Fund, Ltd.8.46%3,600,000
David Kroin8.46%3,600,000

Source

View original at SEC

Related